[go: up one dir, main page]

DK123987A - N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE - Google Patents

N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE

Info

Publication number
DK123987A
DK123987A DK123987A DK123987A DK123987A DK 123987 A DK123987 A DK 123987A DK 123987 A DK123987 A DK 123987A DK 123987 A DK123987 A DK 123987A DK 123987 A DK123987 A DK 123987A
Authority
DK
Denmark
Prior art keywords
derivatives
hydroxyphenyl
methylene
preparing
procedure
Prior art date
Application number
DK123987A
Other languages
Danish (da)
Other versions
DK123987D0 (en
Inventor
Jacques Comarmond
Thomas Purcell
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of DK123987D0 publication Critical patent/DK123987D0/en
Publication of DK123987A publication Critical patent/DK123987A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
DK123987A 1986-03-12 1987-03-11 N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE DK123987A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8603489A FR2595695B1 (en) 1986-03-12 1986-03-12 DERIVATIVES OF N - (((HYDROXY-2 PHENYL) (PHENYL) METHYLENE) AMINO-2) ETHYL) ACETAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (2)

Publication Number Publication Date
DK123987D0 DK123987D0 (en) 1987-03-11
DK123987A true DK123987A (en) 1987-09-13

Family

ID=9333030

Family Applications (1)

Application Number Title Priority Date Filing Date
DK123987A DK123987A (en) 1986-03-12 1987-03-11 N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE

Country Status (12)

Country Link
EP (1) EP0239461A1 (en)
JP (1) JPS62230767A (en)
KR (1) KR870008842A (en)
AU (1) AU6991087A (en)
DK (1) DK123987A (en)
FI (1) FI871067A7 (en)
FR (1) FR2595695B1 (en)
HU (1) HUT43820A (en)
IL (1) IL81858A0 (en)
NO (1) NO870998L (en)
PT (1) PT84452B (en)
ZA (1) ZA871766B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS103091A3 (en) * 1991-04-12 1992-10-14 Ustav Organicke Chemie A Bioch Protected substituted benzhydrylamines as shoulders for the synthesis ofpeptides on solid phase, process of their preparation and use
JP3469579B2 (en) * 1993-06-21 2003-11-25 セレクタイド コーポレーション Selectively cleavable linkers based on iminodiacetic acid ester bonds
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
WO1998046628A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
CA2285659A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
CA2285335A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
EP1611116A2 (en) * 2003-04-08 2006-01-04 Neuromed Technologies, Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319338A1 (en) * 1975-08-01 1977-02-25 Synthelabo NEW A-PHENYL BENZYLIDENIC DERIVATIVES OF AMINO ACIDS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
FR2516509B1 (en) * 1981-11-18 1985-07-26 Synthelabo BENZYLIDENIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
AU6991087A (en) 1987-09-17
NO870998L (en) 1987-09-14
PT84452B (en) 1989-03-17
HUT43820A (en) 1987-12-28
NO870998D0 (en) 1987-03-11
DK123987D0 (en) 1987-03-11
KR870008842A (en) 1987-10-21
FI871067A7 (en) 1987-09-13
PT84452A (en) 1987-04-01
FR2595695A1 (en) 1987-09-18
JPS62230767A (en) 1987-10-09
FI871067A0 (en) 1987-03-11
IL81858A0 (en) 1987-10-20
EP0239461A1 (en) 1987-09-30
ZA871766B (en) 1987-09-01
FR2595695B1 (en) 1988-12-02

Similar Documents

Publication Publication Date Title
DK163991C (en) DICHLORANILIN DERIVATIVES, PROCEDURE FOR PREPARING THESE, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE DERIVATIVES
DK654589A (en) HETEROCYCLIC DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
TR24840A (en) PROCEDURE AND DEVICE FOR THE IDENTIFICATION OF ERRORS
DK74087D0 (en) INDOLICINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF AND MENTALS CONTAINING THE DERIVATIVES
DK28787D0 (en) THIENO-1,4-DIAZEPINE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
DK219387D0 (en) AMINOTHIAZOL AND AMINOOXAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK123987D0 (en) N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE
DK343388D0 (en) 2,2-DIMETHYLCHROMAN-3-OL DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL AGENTS
DK397387D0 (en) CARBOSTYRIC DERIVATIVES AND SALTS THEREOF, AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS
DK542584D0 (en) 1,3-DIHYDRO-6-VINYL-7-HYDROXY-FURO- (3,4-C) PYRIDINE DERIVATIVES, PROCEDURE FOR PREPARING THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK49289D0 (en) MEDICINAL CONTAINING LACTAMES, SUBSTITUTED LACTAMES CONCERNED, AND PROCEDURES FOR PREPARING THEM
DK545684A (en) 1,3-DIHYDRO-6-METHYL-FURO- (3,4-C) -PYRIDINE DERIVATIVES, PROCEDURE FOR PREPARING THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
NO891151D0 (en) ARYLPIPERAZINYLALCOXY DERIVATIVES OF CYCLIC IMIDES, AND PROCEDURES FOR PREPARING THEREOF.
DK642588A (en) INDANDER DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK486789D0 (en) BENZOXAZOLINON DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK342187A (en) 4-PYRIDINE DERIVATIVES, PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK479889A (en) SULFATED OLIGOSACCHARIDES AND DERIVATIVES THEREOF, AND PROCEDURE FOR THE PREPARATION OF SAME
DK114189A (en) BENZOCYCLOHEPTENDER DERIVATIVES, AND MEDICINAL PRODUCTS CONTAINING SUCH COMPOUNDS
DK553689D0 (en) PHENYLOXYPROPANOLAMINE DERIVATIVES, PROCEDURE FOR PREPARING SUCH COMPOUNDS, AND MEDICINAL CONTAINING THESE
DK115289D0 (en) TRICYCLIC AMINE DERIVATIVES, PROCEDURES FOR PREPARING THEM, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK538089A (en) Hitherto unknown TYLOSIN DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK268889D0 (en) CYCLIC D-CYS6 PEPTID RELATIONS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THESE
DE3879349D1 (en) N- (L-ASPARTYL) AMINO ALCOHOL DERIVATIVES AND SWEETENERS CONTAINING THEM.
DK404587D0 (en) 5-DEOXY-5-FLOURCANAMYCINE B DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
DK379287D0 (en) 1,3-PROPANDIAMINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment